Nandini S. Kishore

646 total citations
15 papers, 576 citations indexed

About

Nandini S. Kishore is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Nandini S. Kishore has authored 15 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Infectious Diseases and 4 papers in Organic Chemistry. Recurrent topics in Nandini S. Kishore's work include HIV Research and Treatment (4 papers), Peptidase Inhibition and Analysis (4 papers) and HIV/AIDS drug development and treatment (4 papers). Nandini S. Kishore is often cited by papers focused on HIV Research and Treatment (4 papers), Peptidase Inhibition and Analysis (4 papers) and HIV/AIDS drug development and treatment (4 papers). Nandini S. Kishore collaborates with scholars based in United States, India and Canada. Nandini S. Kishore's co-authors include Balekudru Devadas, Jeffrey I. Gordon, Pramod P. Mehta, S P Adams, Martin L. Bryant, Charles A. McWherter, Sandra K. Freeman, James A. Sikorski, Taotao Lu and David A. Rudnick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Nandini S. Kishore

15 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nandini S. Kishore United States 11 354 149 124 122 100 15 576
Balekudru Devadas United States 18 609 1.7× 196 1.3× 266 2.1× 181 1.5× 133 1.3× 31 938
Sandra K. Freeman United States 14 344 1.0× 101 0.7× 151 1.2× 153 1.3× 62 0.6× 25 666
Rajiv S. Bhatnagar United States 7 572 1.6× 129 0.9× 55 0.4× 54 0.4× 184 1.8× 8 747
D.K. Stammers United Kingdom 13 443 1.3× 157 1.1× 87 0.7× 143 1.2× 42 0.4× 14 652
J. Wielens Australia 14 516 1.5× 63 0.4× 82 0.7× 137 1.1× 83 0.8× 17 740
L.R. Olsen United States 9 495 1.4× 132 0.9× 132 1.1× 68 0.6× 41 0.4× 12 636
A. Yaremchuk Ukraine 12 1.2k 3.3× 161 1.1× 159 1.3× 73 0.6× 41 0.4× 32 1.4k
Tavner J. Delcamp United States 17 611 1.7× 185 1.2× 126 1.0× 91 0.7× 47 0.5× 29 814
Jeanne S. Chang United States 10 391 1.1× 63 0.4× 217 1.8× 70 0.6× 21 0.2× 16 691
Gabriela Mustata United States 14 351 1.0× 60 0.4× 102 0.8× 101 0.8× 17 0.2× 17 592

Countries citing papers authored by Nandini S. Kishore

Since Specialization
Citations

This map shows the geographic impact of Nandini S. Kishore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nandini S. Kishore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nandini S. Kishore more than expected).

Fields of papers citing papers by Nandini S. Kishore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nandini S. Kishore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nandini S. Kishore. The network helps show where Nandini S. Kishore may publish in the future.

Co-authorship network of co-authors of Nandini S. Kishore

This figure shows the co-authorship network connecting the top 25 collaborators of Nandini S. Kishore. A scholar is included among the top collaborators of Nandini S. Kishore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nandini S. Kishore. Nandini S. Kishore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kaushik, Ajeet, et al.. (2012). Study of structural and optical properties of lead borate glasses containing transition metal ion. AIP conference proceedings. 567–568. 7 indexed citations
2.
Rani, Sunita, et al.. (2008). Study of electron paramagnetic resonance in vanadyl doped tungsten lithium borate glasses. Indian Journal of Pure & Applied Physics. 46(6). 382–384. 3 indexed citations
3.
Seth, V. P., et al.. (2005). Electron paramagnetic resonance, optical and electrical properties of vanadyl doped alkali germanoborate glasses. Journal of Physics and Chemistry of Solids. 66(5). 766–772. 7 indexed citations
4.
Devadas, Balekudru, Sandra K. Freeman, Charles A. McWherter, et al.. (1998). Novel Biologically Active Nonpeptidic Inhibitors of MyristoylCoA:Protein N-Myristoyltransferase. Journal of Medicinal Chemistry. 41(6). 996–1000. 40 indexed citations
5.
Sikorski, James A., Balekudru Devadas, Mark E. Zupec, et al.. (1997). Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: Protein N-myristoyltransferase: A new approach to antifungal therapy. Biopolymers. 43(1). 43–71. 46 indexed citations
7.
Nagarajan, Srinivasan, Balekudru Devadas, Mark E. Zupec, et al.. (1997). Conformationally Constrained [p-(ω-Aminoalkyl)phenacetyl]-l-seryl-l-lysyl Dipeptide Amides as Potent Peptidomimetic Inhibitors of Candida albicans and Human Myristoyl-CoA:Protein N-Myristoyl Transferase. Journal of Medicinal Chemistry. 40(10). 1422–1438. 40 indexed citations
8.
Lodge, Jennifer K., Emily Jackson-Machelski, Balekudru Devadas, et al.. (1997). N-Myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA:protein N-myristoyltransferase. Microbiology. 143(2). 357–366. 37 indexed citations
9.
Bryant, Martin L., Charles A. McWherter, Nandini S. Kishore, George W. Gokel, & Jeffrey I. Gordon. (1993). MyristolyCoA:protein N-myristoyltransferase as a therapeutic target for inhibiting replication of human immunodeficiency virus-1. Perspectives in Drug Discovery and Design. 1(1). 193–209. 8 indexed citations
10.
Kishore, Nandini S., David C. Wood, Pramod P. Mehta, et al.. (1993). Comparison of the acyl chain specificities of human myristoyl-CoA synthetase and human myristoyl-CoA:protein N-myristoyltransferase.. Journal of Biological Chemistry. 268(7). 4889–4902. 71 indexed citations
11.
Devadas, Balekudru, Nandini S. Kishore, Steven P. Adams, & Jeffrey I. Gordon. (1993). Synthesis of myristic acid analogs with anti-HIV activity that may be resistant to metabolic processing by β-oxidation. Bioorganic & Medicinal Chemistry Letters. 3(4). 779–784. 14 indexed citations
13.
Bryant, Martin L., Lee Ratner, Robert J. Duronio, et al.. (1991). Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.. Proceedings of the National Academy of Sciences. 88(6). 2055–2059. 63 indexed citations
14.
Kishore, Nandini S., Laura J. Knoll, Akira Katoh, et al.. (1991). The substrate specificity of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. Analysis of myristic acid analogs containing oxygen, sulfur, double bonds, triple bonds, and/or an aromatic residue. Journal of Biological Chemistry. 266(14). 8835–8855. 87 indexed citations
15.
Kishore, Nandini S., et al.. (1988). The fluid-phase binding of human C4 and its genetic variants, C4A3 and C4B1, to immunoglobulins. Molecular Immunology. 25(9). 811–819. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026